We’re moving into a prime advocacy period. This is the second of a series of blogs on advocacy that are going to appear over the next month. The first focused on the big advocacy event of the year – the Solve ME/CFS Initiative’s Lobby Day. If...
An impaired baroreflex response could be contributing to the pain, fatigue, sleep and cognitive issues in fibromyalgia, chronic fatigue syndrome and postural orthostatic tachycardia syndrome (POTS)
The fibromyalgia and chronic fatigue syndrome coronavirus side-effects poll suggested that seventy-plus percent of people are recovering quickly from side effects produced by the Pfizer, Moderna and AstraZeneca (first shot only) vaccines.
A retrospective study suggests that low dose Abilify is safe and may be helpful in reducing fatigue and post-exertional malaise and improving cognition and sleep in chronic fatigue syndrome. A placebo-controlled study is needed to determine how effective low dose Abilify is.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.